Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Events, News and Seminars
Researchers guide better use of medicines
Posted on: 11 September, 2020
With the majority of older Australians taking five or more medications, a team from the Kolling Inst..... Read more
Category: Research Excellence
New medication may offer long-acting relief for those with knee osteoarthritis
Posted on: 10 September, 2020
A study has been launched to investigate the benefits of a new injectable medication for those with..... Read more
Category: New Treatment
Researchers assess new approach to post-operative care
Posted on: 27 August, 2020
With increasing evidence around the benefits of physiotherapy after surgery, a project is set to get..... Read more
Category: New Treatment